medigraphic.com

2017, Number S1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2017; 55 (S1)

Spinal tuberculosis: experience in a third level medical facility in Puebla, Mexico

Medina-Peñasco RJ, Rosas-Ramírez MI, Barragán-Hervella RG, Alvarado-Ortega I, López-Cázares G, Montiel-Jarquín ÁJ, Romero-Figueroa MS

Language: Spanish
References: 21
Page: 80-84
PDF size: 276.79 Kb.


ABSTRACT

Background: Pott’s disease or spinal tuberculosis (STB) is a serious infectious disease, caused by the migration of the bacterium Mycobacterium tuberculosis to the spine. Knowing this disease is a priority for all the physicians. The objective was to show the experience in patients with STB treated in a third level hospital in Puebla, Mexico.
Methods: Descriptive study. From January to December, 2014, we collected information of patients with STB. The variables were age, gender, length of hospital stay, affected segment of the spine, associated diseases, symptoms, diagnostic methods, type of treatment and complication. We used descriptive statistics, as well as measures of central tendency and dispersion.
Results: We studied 14 patients, 71.4 % male; mean age was 60.29 ± 16.54 years (33-93); the average hospital stay was 18.93 ± 9.32 days (4-34). The affected segment was thoracic in six patients (42.85%) and lumbar in eight (57.15%). Nine patients had associated diseases (64.28%) and five did not (35.7%). All patients received medical treatment and 11 surgical procedures were performed in a total of five patients (35.7%). Complications occurred in two patients (14.3%).
Conclusions: STB must be managed early to avoid complications. Coordination with the first level of medical care is very important, as well as the adherence to national and international guidelines.


REFERENCES

  1. Medina-Peñasco RJ. Presentación clínica y manejo de la tuberculosis de columna vertebral, en pacientes de la Unidad Médica de Alta Especialidad, Hospital de Traumatología y Ortopedia de Puebla [tesis de especialidad en Traumatología y Ortopedia]. Puebla, México: Benemérita Universidad Autónoma de Puebla-Instituto Mexicano del Seguro Social; 2016.

  2. Alavi SM, Sharifi M. Tuberculous spondilytis risk factors and clinical & paraclinical aspects in the south west of Iran. J Infect Public Health. 2010;3(4):196- 200. doi: 10.1016/j.jiph.2010.09.005.

  3. Pertuiset E, Beaudreuil J, Liote F, Horusitziky A, Kemiche F, Richette P, et al. Spinal tuberculosis in adults. A study of 103 cases in a developed country, 1980- 1994. Medicine (Baltimore). 1999;78(5): 309-20.

  4. Raviglione MC, O’Brien RJ. Tuberculosis. En Kasper D, Braunwald E. Harrison TR, et al (eds.). Harrison Principios de Medicina Interna. Decimosexta edición. New York: McGraw-Hill/ Interamericana; 2006. p. 1062.

  5. Horsburgh CR Jr, Feldman S, Ridzon R; Infectious Diseases Society of America. Practice guidelines for the treatment of tuberculosis. Clin Infect Dis. 2000;31:633-9.

  6. Cormican L, Hammal R, Messenger J, Milburn HJ. Current difficulties in the diagnosis and management of spinal tuberculosis. Postgrad Med J. 2006; 82(963):46-51.

  7. American Thoracic Society/Centers for Disease Control and Prevention. Treatment of Tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med. 1994:149:1359-74.

  8. Quintela-Martínez AM, Cobelo-Romero E, García-Moreno A. Valoración clínico-epidemiológica de las espondilodiscitis y resultado funcional tras su tratamiento: Serie de casos. Rev Col Or Tra. 2013;27(1):22-31.

  9. [No authors listed] Controlled trial of short-course regimens chemotherapy in the ambulatory treatment of the spinal tuberculosis: results at three years of a study in Korea. Twelfth report of the medical Research Council Working Party on Tuberculosis of the Spine. J Bone Joint Surg Br. 1993;75(2):240-8.

  10. Baksh A. Medical management of spinal tuberculosis: an experience from Pakistan. Spine (Phila Pa 1976). 2010 Jul 15;35(16):E787-91. doi: 10.1097/ BRS.0b013e3181d58c3c.

  11. Cañabate-Reche F, Daza-Torres A, Campos-Aguilera A, López-Prieto F, Vázquez-López M, López Muñoz. Tuberculosis osteoarticular en la infancia: una realidad en nuestro medio. An Esp Pediatr. 1997;46:73-6.

  12. Friedman B. Chemotherapy of tuberculosis of the spine. J Bone Joint Surg (Am). 1996;48:451-74.

  13. Ahmed EG, Elbadawi NEE, Ibrahim EK, Mohammed MM. Clinical Presentations of Pott’s disease of the Spine in Adult Sudanese Patients. J Med Microb Diagn. 2013;2:120. doi: 10.4172/2161-0703.1000120

  14. Benzagmout M, Boujraf S, Chakour K, Chaoui MEF. Pott's disease in children. Surg Neurol Int. 2011;(2)1: doi: 10.4103/2152-7806.75459

  15. García-Lechuz JM, Julve R, Alcalá L, Ruiz-Serrano MJ, Muñoz P. Espondilodiscitis tuberculosa o enfer medad de Pott: experiencia en un hospital general. Enferm Infecc Microbiol Clin. 2002;20(1):5-9.

  16. Elbashir G Ahmed, Nour Eldaim E Elbadawi , Elwathiq KI, Mamoun MM. Clinical Presentation of Pott’s disease of the Spine in Adult Sudanese Patients. J. Med Microb Diag. 2013;2:2. doi:10.4172/2161-0703.1000120

  17. Wisneski RJ. Infectious disease of the spine, diagnostic and treatment considerations. Orthop Clin North AM. 1999;22:491-500.

  18. Allen SL, Batungwanayo J, Kerlikowske K, Lifson AR, Wolf W, Granich R, et al. Two-year incidence of tuberculosis in cohorts of HIV infected and uninfected urban Rwandan women. Am Rev Respir Dis. 1992;146:1439-44.

  19. Gilks Ch, Vitoria M. Antiretroviral Therapy for HIV Infection in Adults and Adolescents in Resource-Limited Settings: Towards Universal Access. Recommendations for a Public Health Approach. Geneva: World Health Organization; 2010.

  20. Gilks Ch, Vitoria M. Antiretroviral Therapy for HIV Infection in Adults and Adolescents in Resource-Limited Settings: Towards Universal Access. Recommendations for a Public Health Approach. Geneva: World Health Organization; 2010.

  21. World Health Organization (WHO). Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents. Recommendation for HIV-prevalent and resource-constrained settings. Geneva: WHO; 2007. Disponible en: http://whqlibdoc.who.int/ hq/2007/WHO_HTM_TB_2007.379_eng.pdf




2020     |     www.medigraphic.com